Srividya Kotapati
About Srividya Kotapati
Srividya Kotapati is the Senior Medical Director of Oncology-Melanoma, Breast & Gyn, Medical Innovation at Bristol Myers Squibb in Princeton, New Jersey, with over 20 years of experience in the pharmaceutical industry and healthcare.
Current Title and Role
Srividya Kotapati currently holds the position of Senior Medical Director, Oncology-Melanoma, Breast&Gyn, Medical Innovation at Bristol Myers Squibb in Princeton, New Jersey, United States. In this role, she focuses on medical innovation within the fields of melanoma, breast, and gynecologic oncology.
Career at Bristol Myers Squibb
Srividya Kotapati has had a long-standing career at Bristol Myers Squibb with multiple roles over the years. She served as Group Director, VAP/HEOR Oncology from 2014 to 2020, Director, HEOR Oncology from 2011 to 2014, and Associate Director, GHEOR Oncology from 2006 to 2011. Her tenure included significant responsibilities in health economics and outcomes research related to oncology.
Previous Experience in Healthcare
Before her tenure at Bristol Myers Squibb, Srividya Kotapati worked at the University of Massachusetts Medical School-MA State Medicaid program as the Associate Director of the Massachusetts Medicaid Program from 2004 to 2006. Additionally, she gained experience at Hartford Hospital as a Fellow and Resident specializing in Antibiotic Management, Pharmacoeconomics, and Infectious Diseases from 2001 to 2004.
Educational Background
Srividya Kotapati obtained her Doctor of Pharmacy (PharmD) from the Albany College of Pharmacy of Union University, completing her studies from 1999 to 2001. She also holds a Bachelor of Science in Pharmacy from Kakatiya University, University College of Pharmaceutical Sciences, where she studied from 1994 to 1998.
Professional Expertise
With over 20 years of experience in the healthcare industry, Srividya Kotapati has specialized in Immuno-Oncology for over 15 years. Her expertise spans multiple therapeutic areas, including Hematology, Virology, Infectious Diseases, Antibiotic Management, Critical Care, and Gastroenterology. She is recognized as a leader in Medical Affairs and health economics, with extensive experience in regulatory filings, launch experience, and payer interactions.
Published Works and Contributions
Srividya Kotapati has authored more than 100 peer-reviewed publications in renowned journals and presented at key congresses. Her contributions have provided valuable insights into various therapeutic areas and helped advance the understanding of healthcare economics and oncology treatments.